EUVIMEDEUVIMED entdecken
Crossref

2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors

Shasha Xu, Jiaou Chen, Chunfei Xu, Ye Xu, Lu Xu, Meiqi Zhao, Tong Xu, Yungang Cao, Peijun Li, Zhao Han

Brain Research · 2024

DOI: 10.1016/j.brainres.2024.149284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Shasha Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Department of C…. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Ischemic Stroke, Neuroprotective Agents, Rats, Sprague-Dawley. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: The intricate roles of NMDA receptors, specifically those containing the NR2A or NR2B subunit, in ischemic stroke pathology necessitate targeted therapeutic investigations. Building on our prior discovery showcasing the neuroprotective potential of 2-(benzofuran-2-yl)-2-imidazoline (2-BFI), an imidazoline I2 receptor ligand, in inhibiting NMDA receptor currents during ischemic stroke, this study aims to elucidate the specific impact of 2-BFI on NR2A- and NR2B-containing NMDARs. EXPERIMENTAL APPROACH: Through whole-cell patch-clamp techniques, we observed an inhibition by 2-BFI on NR2A-containing NMDAR currents (IC50 = 238.6 μM) and NR2B-containing NMDAR currents (IC50 = 18.47 μM). Experiments with HEK293 cells expressing exogenous receptor subunits revealed a significantly higher affinity of 2-BFI towards NR2B-containing NMDARs. In vivo studies involved the co-administration of 2-BFI and the NR2A subunit antagonist NVP-AAM077 in rats subjected to transient middle cerebral artery occlusion (tMCAO). Key results 2-BFI exhibited a pronounced preference for inhibiting NR2B-containing NMDAR currents, leading to a notable mitigation of cerebral ischemic injury when administered in conjunction with NVP-AAM077 in the tMCAO rat model. Furthermore, alterations in the expression of downstream proteins specific to NR2B-containing NMDA receptors were observed, suggesting targeted molecular effects. Conclusion and implications This study unveils the neuroprotective potential of 2-BFI in ischemic stroke by selectively inhibiting NR2B-containing NMDA receptors. These findings lay the foundation for precise therapeutic strategies, showcasing the differential roles of NR2A and NR2B subunits and paving the way for advancements in targeted interventions for ischemic stroke treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateIschemic StrokeNeuroprotective AgentsRats, Sprague-DawleyBenzofuransAnimalsHumansHEK293 CellsMaleRatsImidazolesBrain IschemiaPatch-Clamp Techniques

Stichwörter der Autor:innen

2-BFIExcitotoxicityIschemic strokeNMDA receptorPatch-clamp

Substanzen

Receptors, N-Methyl-D-AspartateNR2B NMDA receptorNeuroprotective AgentsBenzofurans2-(2-benzofuranyl)-2-imidazolineImidazolesNR2A NMDA receptor

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Department of Critical Care Medicine, Taizhou Hospital of Zhejiang Province Affiliate…
  • Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address: zhaohan@wmu.edu.cn.

Förderung

  • Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Xu, S., Chen, J., Xu, C., Xu, Y., Xu, L., Zhao, M., Xu, T., Cao, Y., Li, P., & Han, Z. (2024). 2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors. Brain Research. https://doi.org/10.1016/j.brainres.2024.149284

Vancouver

Xu S, Chen J, Xu C, Xu Y, Xu L, Zhao M, et al. 2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors. Brain Research. 2024. doi:10.1016/j.brainres.2024.149284

BibTeX
@article{Xu2024,
  author = {Xu, Shasha and Chen, Jiaou and Xu, Chunfei and Xu, Ye and Xu, Lu and Zhao, Meiqi and Xu, Tong and Cao, Yungang and Li, Peijun and Han, Zhao},
  title = {2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors},
  journal = {Brain Research},
  year = {2024},
  doi = {10.1016/j.brainres.2024.149284}
}
Kostenlos starten →